10x Genomics Inc · Analyst Forecasts
What Wall Street expects this business to earn, and how much analysts disagree.
Are estimates going up or down lately?
We hold no completed revision window for 10x Genomics yet. A revision needs two of our own nightly snapshots of one fiscal period to compare, and nothing before the first is reconstructed, because a backfilled revision is a number we never observed.
Measured between two of our own nightly snapshots of one fiscal period, so a new fiscal year entering the view is never read as a revision. Never backfilled. A window still filling says how many days it holds; a blank one means our record is not that long yet.
What you pay for the growth
Growth over a negative base is not meaningful. Consensus EPS is a loss in , so there is neither a multiple of those earnings to pay nor a rate to grow from.
Analysts' price forecasts and grades are not licensed here. This page shows forward consensus estimates only: no near-year analyst count published. Not investment advice.